相关实验视频

Updated: Jul 18, 2025

In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy

In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy

Published on: July 29, 2019

通过动态对比增强MRI观察到小鼠大脑中脑脊液标记物的运输途径和动力学

Yuran Zhu¹, Guanhua Wang², Chaitanya Kolluru¹

¹Department of Biomedical Engineering, Case Western Reserve University, Wickenden 430, 10900 Euclid Avenue, Cleveland, OH, 44106, USA.

Scientific reports

|August 24, 2023

概括

淋巴系统清理大脑的废物. 动态对比增强型MRI (DCE-MRI) 显示,富含氧17的水运输速度比加多剂更快,揭示了大小依赖的大脑废物清除途径.

科学领域:

神经科学是一个神经科学.
生物物理学的生物物理.
医疗成像医学成像

背景情况:

淋巴系统对于大脑的废物清理至关重要.
动态对比增强型MRI (DCE-MRI) 是评估淋巴功能的一个关键工具.
了解对比剂运输对于评估淋巴管道至关重要.

研究的目的:

在小鼠中评估不同分子大小的三种MRI对比剂的运输动力学和分布.
为了比较氧气-17丰富水 (H217O) 的淋巴运输与两种基于加多的对比剂 (Gd-DTPA和GadoSpin).
研究分子大小对溶解物运输通路和淋巴系统内的动力学的影响.

主要方法:

在小鼠模型中使用动态对比增强MRI (DCE-MRI).
在内注射了三种对比剂:H217O,Gd-DTPA和GadoSpin.
应用时间滞后的相关性和聚类分析来评估运输路径和动力学.

主要成果:

H217O显示出比Gd-DTPA和GadoSpin.显著更快,更广泛的运输速度.
对于H217O和Gd-DTPA,已经确定了不同的传输路径.
观察到侧腔室的运输动力学有显著差异,反映出不同的溶液运输力.

结论:

对比剂的分子大小显著影响淋巴体运输通路和动力学.
DCE-MRI是一种多功能工具,用于评估淋巴系统中溶液运输的多个方面.
这些发现凸显了药剂性质在淋巴系统研究中的重要性.

更多相关视频

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

Published on: June 8, 2017

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers

Published on: February 26, 2018

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...